Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. Preclinical tests showed that the company's signature therapy, Telomir-1, appeared to address insulin resistance and achieving reversal to near pre-diabetic levels. These results add to previous testing results showing a myriad of potential life improving and extending benefits.

03 Dec 2024
TELO: Another Potential Breakthrough

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
TELO: Another Potential Breakthrough
Telomir Pharmaceuticals, Inc. (TELO:NAS) | 0 0 0.0%
- Published:
03 Dec 2024 -
Author:
Brad Sorensen -
Pages:
7 -
Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. Preclinical tests showed that the company's signature therapy, Telomir-1, appeared to address insulin resistance and achieving reversal to near pre-diabetic levels. These results add to previous testing results showing a myriad of potential life improving and extending benefits.